Drug Search Results

MK-0773

Alternative Names: mk-0773, mk0773, mk 0773
Latest Update: 2023-09-25
Latest Update Note: News Article

Product Description

selective androgen receptor modulator (Sourced from: https://pubmed.ncbi.nlm.nih.gov/20356837/)

Mechanisms of Action: SARM Modulator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Merck
Company Location: KENILWORTH NJ 07033
Company CEO: Robert M. Davis
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for MK-0773

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Sarcopenia

Phase 1: Healthy Volunteers|Osteoporosis

Trial	Phase	Trial Status	Disease	Primary Completion Date
Sarcopenia Study	P2	Completed	Sarcopenia	2009-10-01
MK-0773-005	P2	Completed	Sarcopenia	2009-10-01
MK-0773-004	P1	Completed	Healthy Volunteers	2008-08-01
MK0773-003	P1	Completed	Osteoporosis	2006-04-01

Recent News Events

Date	Type	Title
09/25/2023	News Article	Sarcopenia Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 (Updated)
12/15/2021	PubMed	Development and validation of SARMs and metabolic modulators screening in hair using UHPLC-MS/MS: Application to a doping case and first identification of S23 in authentic human hair.
02/20/2021	PubMed	Simultaneous detection of different chemical classes of selective androgen receptor modulators in urine by liquid chromatography-mass spectrometry-based techniques.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions